$OPCH
Option Care Health, Inc. Stock $opch

$opch Overview Financials Valuation SEC Filings Company Website

2011 Form 10-K Financial Statement

#000101473912000004 Filed on March 14, 2012

Income Statement

Concept	2011	2010 Q4	2009
Revenue	$1.818B	-$757.5M	$1.330B
YoY Change	322.11%	-321.75%	-5.16%
Cost Of Revenue	$339.1M	-$730.3M	$1.172B
YoY Change	25.5%	-343.76%	-6.99%
Gross Profit	$215.4M	-$27.30M	$157.8M
YoY Change	34.21%	-165.16%	10.99%
Gross Profit Margin	11.85%		11.87%
Selling, General & Admin	$178.6M	-$18.90M	$140.6M
YoY Change	27.03%	-146.32%	8.91%
% of Gross Profit	82.91%		89.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$6.591M	$300.0K	$5.033M
YoY Change	163.64%	-78.57%	-21.36%
% of Gross Profit	3.06%		3.19%
Operating Expenses	$182.0M	-$18.60M	$140.6M
YoY Change	27.27%	-145.59%	7.33%
Operating Profit	$25.55M	-$8.700M	$15.47M
YoY Change	46.02%	-890.91%	38.09%
Interest Expense	$25.54M	-$4.000M	$1.920M
YoY Change	-208.23%	900.0%	-171.11%
% of Operating Profit	99.96%		12.41%
Other Income/Expense, Net
YoY Change
Pretax Income	$11.00K	-$18.90M	$13.55M
YoY Change	-100.06%	1618.18%	-115.71%
Income Tax	$435.0K	$46.70M	-$40.55M
% Of Pretax Income	3954.55%		-299.37%
Net Earnings	$7.872M	-$67.10M	$54.10M
YoY Change	-111.39%	-264.86%	-173.11%
Net Earnings / Revenue	0.43%		4.07%
Basic Earnings Per Share	$0.14		$1.39
Diluted Earnings Per Share	$0.14	-$5.083M	$1.36
COMMON SHARES
Basic Shares Outstanding	54.51M shares		38.99M shares
Diluted Shares Outstanding	54.51M shares		39.74M shares

Balance Sheet

Concept	2011	2010 Q4	2009
SHORT-TERM ASSETS
Cash & Short-Term Investments	$0.00	$0.00	$0.00
YoY Change
Cash & Equivalents	$0.00	$0.00
Short-Term Investments
Other Short-Term Assets	$49.10M	$16.70M	$16.90M
YoY Change	194.01%	-1.18%	503.57%
Inventory	$18.00M	$66.51M	$52.70M
Prepaid Expenses
Receivables	$225.4M	$193.7M	$149.7M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$292.5M	$276.9M	$219.3M
YoY Change	5.63%	26.28%	6.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$27.00M	$23.92M	$15.50M
YoY Change	12.97%	54.32%	5.44%
Goodwill		$312.4M
YoY Change
Intangibles		$30.10M
YoY Change
Long-Term Investments	$0.00
YoY Change
Other Assets	$25.70M	$3.841M	$28.00M
YoY Change	188.76%	-86.28%	2445.45%
Total Long-Term Assets	$384.6M	$387.1M	$67.90M
YoY Change	-0.65%	470.05%	68.07%
TOTAL ASSETS
Total Short-Term Assets	$292.5M	$276.9M	$219.3M
Total Long-Term Assets	$384.6M	$387.1M	$67.90M
Total Assets	$677.1M	$664.0M	$287.2M
YoY Change	1.97%	131.19%	16.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.20M	$80.81M	$74.50M
YoY Change	-1.98%	8.48%	-3.12%
Accrued Expenses	$38.50M	$41.80M	$14.30M
YoY Change	-7.89%	192.31%	48.96%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$66.20M	$81.35M	$30.40M
YoY Change	-18.67%	167.61%
Total Short-Term Liabilities	$220.8M	$226.8M	$128.2M
YoY Change	-2.65%	76.9%	-13.26%
LONG-TERM LIABILITIES
Long-Term Debt	$227.3M	$225.1M	$0.00
YoY Change	0.98%
Other Long-Term Liabilities	$3.500M	$2.838M	$3.200M
YoY Change	25.0%	-11.31%	3.23%
Total Long-Term Liabilities	$230.8M	$228.0M	$3.200M
YoY Change	1.27%	7023.59%	3.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$220.8M	$226.8M	$128.2M
Total Long-Term Liabilities	$230.8M	$228.0M	$3.200M
Total Liabilities	$461.8M	$463.9M	$131.4M
YoY Change	-0.45%	253.03%	-13.21%
SHAREHOLDERS EQUITY
Retained Earnings		-$157.7M
YoY Change
Common Stock		$368.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)		$10.50M
YoY Change
Treasury Stock Shares		2.642M shares
Shareholders Equity	$215.3M	$200.1M	$155.8M
YoY Change
Total Liabilities & Shareholders Equity	$677.1M	$664.0M	$287.2M
YoY Change	1.97%	131.19%	16.28%

Cashflow Statement

Concept	2011	2010 Q4	2009
OPERATING ACTIVITIES
Net Income	$7.872M	-$67.10M	$54.10M
YoY Change	-111.39%	-264.86%	-173.11%
Depreciation, Depletion And Amortization	$6.591M	$300.0K	$5.033M
YoY Change	163.64%	-78.57%	-21.36%
Cash From Operating Activities	$26.97M	-$27.30M	$22.75M
YoY Change	-226.02%	-413.79%	-361.44%
INVESTING ACTIVITIES
Capital Expenditures	-$7.900M	$0.00	-$5.700M
YoY Change	17.91%	-100.0%	-24.0%
Acquisitions	$0.00		$0.00
YoY Change
Other Investing Activities	-$2.100M	-$4.200M	$0.00
YoY Change	-97.93%
Cash From Investing Activities	-$9.907M	-$4.100M	-$5.739M
YoY Change	-90.85%	241.67%	-23.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change	-100.0%
Debt Paid & Issued, Net	$0.00		$0.00
YoY Change
Cash From Financing Activities	-$17.06M	-19.60M	-$17.01M
YoY Change	-113.15%	161.33%	-204.98%
NET CHANGE
Cash From Operating Activities	$26.97M	-27.30M	$22.75M
Cash From Investing Activities	-$9.907M	-4.100M	-$5.739M
Cash From Financing Activities	-$17.06M	-19.60M	-$17.01M
Net Change In Cash	$0.00	-51.00M	$0.00
YoY Change	-100.0%
FREE CASH FLOW
Cash From Operating Activities	$26.97M	-$27.30M	$22.75M
Capital Expenditures	-$7.900M	$0.00	-$5.700M
Free Cash Flow	$34.87M	-$27.30M	$28.45M
YoY Change	-337.2%	-375.76%	-2470.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	79155000	USD
CY2010Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	80814000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	375525000	USD
CY2011	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1055000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3773000	USD
CY2009	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2010Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	368254000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	3773000	USD
CY2009	us-gaap	Adjustment For Amortization AdjustmentForAmortization	0	USD
CY2011	us-gaap	Adjustment For Amortization AdjustmentForAmortization	5189000	USD
CY2010Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	16421000	USD
CY2011Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	22728000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1813000	USD
CY2009	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2011	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5189000	USD
CY2010Q4	us-gaap	Assets Assets	663986000	USD
CY2011Q4	us-gaap	Assets Assets	677102000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	292469000	USD
CY2010Q4	us-gaap	Assets Current AssetsCurrent	276927000	USD
CY2009	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1774000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	7118000	USD
CY2011	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2008Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
CY2011	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	0	USD
CY2009	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	0	USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00
CY2010Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2010Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2010Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57042803	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	57800791	shares
CY2010Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	54118501	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55109038	shares
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2010Q4	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2011	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1400947000	USD
CY2009	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1119504000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	1303643000	USD
CY2011	us-gaap	Cost Of Revenue CostOfRevenue	1505723000	USD
CY2009	us-gaap	Cost Of Revenue CostOfRevenue	1171703000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1378206000	USD
	us-gaap	Cost Of Services CostOfServices	74563000	USD
CY2009	us-gaap	Cost Of Services CostOfServices	52199000	USD
CY2011	us-gaap	Cost Of Services CostOfServices	104776000	USD
	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	-5766000	USD
CY2009	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	0	USD
CY2011	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	-59000	USD
CY2010Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	5062000	USD
CY2011Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	3992000	USD
CY2011	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1155000	USD
CY2009	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-40517000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	47337000	USD
CY2010Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	9140000	USD
CY2011Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	10295000	USD
CY2011	us-gaap	Depreciation Depreciation	10687000	USD
CY2009	us-gaap	Depreciation Depreciation	5033000	USD
	us-gaap	Depreciation Depreciation	8556000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.37
CY2009	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2011	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2011	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.37
CY2009	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.36
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	120000	USD
CY2011	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2009	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	120000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-350000	USD
CY2009	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	USD
CY2011	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-404000	USD
CY2009	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-9561000	USD
CY2011	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2011Q4	us-gaap	Goodwill Goodwill	324141000	USD
CY2010Q4	us-gaap	Goodwill Goodwill	324141000	USD
CY2009	us-gaap	Gross Profit GrossProfit	157822000	USD
	us-gaap	Gross Profit GrossProfit	260417000	USD
CY2011	us-gaap	Gross Profit GrossProfit	312303000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9195000	USD
CY2009	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	13546000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-21414000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1323000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	47728000	USD
CY2009	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-40553000	USD
CY2011	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1042000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2565000	USD
CY2009	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	741000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1659000	USD
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2944000	USD
CY2009	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-2401000	USD
CY2011	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-9777000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11021000	USD
CY2009	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6029000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9907000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-8433000	USD
CY2009	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1237000	USD
CY2011	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	31690000	USD
CY2009	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-7536000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	4321000	USD
CY2010Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30096000	USD
CY2011Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	25226000	USD
CY2011	us-gaap	Interest Expense InterestExpense	28306000	USD
CY2009	us-gaap	Interest Expense InterestExpense	1920000	USD
	us-gaap	Interest Expense InterestExpense	27647000	USD
CY2011	us-gaap	Interest Paid Net InterestPaidNet	27528000	USD
	us-gaap	Interest Paid Net InterestPaidNet	20116000	USD
CY2009	us-gaap	Interest Paid Net InterestPaidNet	1918000	USD
CY2010Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5766000	USD
CY2011Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	5825000	USD
CY2010Q4	us-gaap	Inventory Net InventoryNet	66509000	USD
CY2011Q4	us-gaap	Inventory Net InventoryNet	56745000	USD
CY2011Q4	us-gaap	Liabilities Liabilities	461823000	USD
CY2010Q4	us-gaap	Liabilities Liabilities	463885000	USD
CY2010Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	663986000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	677102000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	220774000	USD
CY2010Q4	us-gaap	Liabilities Current LiabilitiesCurrent	226790000	USD
CY2009	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	0	USD
CY2011	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	4800000	USD
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3893000	USD
CY2010Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	81352000	USD
CY2011Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	66161000	USD
CY2010Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	225117000	USD
CY2011Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	227298000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17062000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	129702000	USD
CY2009	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17006000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-108283000	USD
CY2009	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5739000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9907000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26969000	USD
CY2009	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	22745000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-21419000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-69142000	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	54099000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	7872000	USD
CY2009	us-gaap	Operating Income Loss OperatingIncomeLoss	15466000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	37501000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	15794000	USD
CY2010Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3841000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1830000	USD
CY2011Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3456000	USD
CY2010Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	2838000	USD
CY2011	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	237274000	USD
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	207007000	USD
CY2009	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	131946000	USD
	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	10850000	USD
CY2009	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	5739000	USD
CY2011	us-gaap	Payments For Proceeds From Productive Assets PaymentsForProceedsFromProductiveAssets	9444000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11583000	USD
CY2009	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2011	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	22000	USD
CY2009	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	92464000	USD
CY2011	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2011	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	463000	USD
CY2009	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	USD
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	USD
CY2010Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00
CY2011Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00
CY2010Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	29444000	USD
CY2009	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	8636000	USD
CY2011Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2011Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2010Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2011Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	19337000	USD
CY2011	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	18654000	USD
CY2010Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	193722000	USD
CY2011Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	225412000	USD
CY2010Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2009	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	0	USD
CY2011Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	4116000	USD
CY2011	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3198000	USD
CY2009	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3015000	USD
CY2011	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1773644000	USD
CY2009	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	1331000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	407277000	USD
CY2009	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2011	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	319000000	USD
CY2011	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-2250000	USD
CY2009	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	0	USD
CY2010Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23919000	USD
CY2011	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	0	USD
	us-gaap	Repayments Of Assumed Debt RepaymentsOfAssumedDebt	128952000	USD
CY2011	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1791058000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	356430000	USD
CY2009	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	1351022000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	2635000	USD
CY2009	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	348000	USD
CY2009	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	100000000	USD
CY2011	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2011	us-gaap	Restructuring Charges RestructuringCharges	8885000	USD
	us-gaap	Restructuring Charges RestructuringCharges	3495000	USD
CY2009	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2009	us-gaap	Revenues Revenues	1329525000	USD
	us-gaap	Revenues Revenues	1638623000	USD
CY2011	us-gaap	Revenues Revenues	1818026000	USD
CY2009	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	1262619000	USD
CY2011	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	1622949000	USD
CY2010Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-157663000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-149791000	USD
	us-gaap	Sales Revenue Goods Gross SalesRevenueGoodsGross	1507995000	USD
CY2011	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	195077000	USD
	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	130628000	USD
CY2009	us-gaap	Sales Revenue Services Gross SalesRevenueServicesGross	66906000	USD
CY2009	us-gaap	Share Based Compensation ShareBasedCompensation	3419000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3320000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	4466000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	200101000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	215279000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	95537000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	155793000	USD
CY2011Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	11766000	USD
CY2010Q4	us-gaap	Supplementary Insurance Information Liability For Future Policy Benefits Losses Claims And Loss Expense Reserves SupplementaryInsuranceInformationLiabilityForFuturePolicyBenefitsLossesClaimsAndLossExpenseReserves	3037000	USD
CY2010Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2642398	shares
CY2011Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2638421	shares
CY2010Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10496000	USD
CY2011Q4	us-gaap	Treasury Stock Value TreasuryStockValue	10461000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50374000	shares
CY2009	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39737000	shares
CY2011	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55150000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50374000	shares
CY2009	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	38985000	shares
CY2011	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54505000	shares
CY2011Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	32648000	USD
CY2010Q4	bios	Accrued Expenses And Other Current Liabilities AccruedExpensesAndOtherCurrentLiabilities	36040000	USD
CY2009	bios	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	4832000	USD
	bios	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	-15497000	USD
CY2011	bios	Accrued Expenses And Other Liabilities AccruedExpensesAndOtherLiabilities	-2945000	USD
CY2009	bios	Amounts Due To Plan Sponsor AmountsDueToPlanSponsor	708000	USD
CY2011	bios	Amounts Due To Plan Sponsor AmountsDueToPlanSponsor	-5437000	USD
	bios	Amounts Due To Plan Sponsor AmountsDueToPlanSponsor	-6079000	USD
CY2011Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	25219000	USD
CY2010Q4	bios	Amounts Due To Plan Sponsors AmountsDueToPlanSponsors	19781000	USD
CY2011	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	6631000	USD
CY2009	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	0	USD
	bios	Capital Lease Obligations Incurred To Acquire Property And Equipment CapitalLeaseObligationsIncurredToAcquirePropertyAndEquipment	671000	USD
CY2009	bios	Cash Consideration Paid For Option Health Earn Out CashConsiderationPaidForOptionHealthEarnOut	0	USD
	bios	Cash Consideration Paid For Option Health Earn Out CashConsiderationPaidForOptionHealthEarnOut	1000000	USD
CY2011	bios	Cash Consideration Paid For Option Health Earn Out CashConsiderationPaidForOptionHealthEarnOut	0	USD
CY2011	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	4969000	USD
CY2009	bios	Cash Consideration Paid To Ds Pharmacy CashConsiderationPaidToDsPharmacy	0	USD
	bios	Claims Payable ClaimsPayable	1030000	USD
CY2009	bios	Claims Payable ClaimsPayable	1162000	USD
CY2011	bios	Claims Payable ClaimsPayable	-8729000	USD
CY2011Q4	bios	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	10312000	USD
CY2010Q4	bios	Prepaid Expenses And Other Current Assets PrepaidExpensesAndOtherCurrentAssets	16696000	USD
CY2011	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	-189000	USD
	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	-128000	USD
CY2009	bios	Surrender Of Stock To Satisfy Minimum Tax Withholding SurrenderOfStockToSatisfyMinimumTaxWithholding	-119000	USD
CY2011	dei	Amendment Flag AmendmentFlag	false
CY2011	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2011	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2011	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2011
CY2011	dei	Document Period End Date DocumentPeriodEndDate	2011-12-31
CY2011	dei	Document Type DocumentType	10-K
CY2011	dei	Entity Central Index Key EntityCentralIndexKey	0001014739
CY2012Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55416754	shares
CY2011	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2011	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2011Q2	dei	Entity Public Float EntityPublicFloat	184882882	USD
CY2011	dei	Entity Registrant Name EntityRegistrantName	BioScrip, Inc.
CY2011	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2011	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No

Files In Submission

Name	View Source	Status
0001014739-12-000004-index-headers.html	Edgar Link	pending
0001014739-12-000004-index.html	Edgar Link	pending
0001014739-12-000004.txt	Edgar Link	pending
0001014739-12-000004-xbrl.zip	Edgar Link	pending
bios-20111231.xml	Edgar Link	completed
bios-20111231.xsd	Edgar Link	pending
bios-20111231x10k.htm	Edgar Link	pending
bios-20111231_cal.xml	Edgar Link	unprocessable
bios-20111231_def.xml	Edgar Link	unprocessable
bios-20111231_lab.xml	Edgar Link	unprocessable
bios-20111231_pre.xml	Edgar Link	unprocessable
bios-ex311x10k.htm	Edgar Link	pending
bios-ex312x10k.htm	Edgar Link	pending
bios-ex321x10k.htm	Edgar Link	pending
bios-ex322x10k.htm	Edgar Link	pending
bioscriplogo.jpg	Edgar Link	pending
biosgraph.jpg	Edgar Link	pending
exhibit211.htm	Edgar Link	pending
exhibit231.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$OPCH
Option Care Health, Inc. Stock $opch

2011 Form 10-K Financial Statement

#000101473912000004 Filed on March 14, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH Option Care Health, Inc. Stock $opch

2011 Form 10-K Financial Statement

#000101473912000004 Filed on March 14, 2012

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$OPCH
Option Care Health, Inc. Stock $opch